Insulin Storage Devices Industry Forecast Report, 2025-2030 - Scarcity of Coverage in Insurance Policies Challenging the Market, Despite it Reaching $1.62 Billion by 2030
21. November 2024 06:36 ET
|
Research and Markets
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Insulin Storage Devices Market by Product, Patient Type - Global Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering.The...
NLRP3 Protein Inhibitors Pipeline Research Report 2024: Therapeutic Assessment of 25+ Drugs by Product Type, Stage, Route of Administration, and Molecule Type
21. November 2024 04:21 ET
|
Research and Markets
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "NLRP3 Protein Inhibitors - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.The report provides...
Insulin Delivery Pipeline Report 2024 - Stages of Development, Segments, Regulatory Path and Key Companies
12. November 2024 08:34 ET
|
Research and Markets
Dublin, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The "Insulin Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update"...
Spain Diabetes Market Report 2024-2032: A $1.32 Billion Industry Opportunity with Insights on Prevalence Trends, Demographical Breakup, Diagnosis and Treatment
17. Oktober 2024 04:12 ET
|
Research and Markets
Dublin, Oct. 17, 2024 (GLOBE NEWSWIRE) -- The "Spain Diabetes Market Report: 2024-2032" report has been added to ResearchAndMarkets.com's offering.The Spain diabetes market size reached US$ 947.9...
$49.3 Bn GLP-1 Markets 2024-2035 with Boehringer Ingelheim, Eli Lilly, Novo Nordisk Dominating
01. Oktober 2024 04:35 ET
|
Research and Markets
Dublin, Oct. 01, 2024 (GLOBE NEWSWIRE) -- The "GLP-1 Market: Industry Trends and Global Forecasts to 2035: Distribution by Type of Molecule, Active Compound Used, Type of GLP-1 Agonist Drugs, Type...
Type 2 Diabetes in the United States: A Review of 2023 - Key Insights into Treatment Awareness & Satisfaction
26. September 2024 04:19 ET
|
Research and Markets
Dublin, Sept. 26, 2024 (GLOBE NEWSWIRE) -- The "Type 2 Diabetes in the United States: A Review of 2023 - Key Insights into Treatment Awareness & Satisfaction" report has been added to ...
Rapid-Acting Insulin Market Expected to Reach $11.17 billion by 2032 | 2024 Research Report
09. September 2024 09:22 ET
|
Research and Markets
Dublin, Sept. 09, 2024 (GLOBE NEWSWIRE) -- The "Rapid Acting Insulin Market Report, Forecast by Product, Indication, Distribution Channel, Countries and Company Analysis 2024-2032" report has been...
embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes
03. September 2024 06:30 ET
|
Embecta Corp.
embecta has received 510(k) clearance from the FDA for its proprietary disposable insulin delivery system, a patch pump with a 300-unit insulin reservoir.
Human Insulin Market to Reach $24.0 Billion, Globally, by 2033 at 3.4% CAGR: Allied Market Research
07. August 2024 09:50 ET
|
Allied Analytics LLP
Wilmington, Delaware, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Human Insulin Market by Product Type (Pens, Syringes and Others), Indication (Type 1...
Global Insulin Pen Market Poised for Expansion, Projected to Reach US$ 10.71 Billion by 2032, Fueled by Technological Advancements and User-Friendly Designs and International Prevalence of Diabetes
24. Juli 2024 11:16 ET
|
Research and Markets
Dublin, July 24, 2024 (GLOBE NEWSWIRE) -- The "Global Insulin Pen Market Report by Product, Disease types, Distribution Channels Regions and Company Analysis 2024-2032" report has been added to ...